Cost-effectiveness of pembrolizumab for first-line treatment in patients with persistent, recurrent, or metastatic cervical cancer in the United States by [email protected] | Oct 30, 2023
Health care resource utilization (HCRU) and costs in patients with biliary tract cancer (BTC) treated with systemic therapy in the United States (US) by [email protected] | Oct 20, 2023
Role of Culture, Values, and Politics in the Implementation of Health Technology Assessment in India: A Commentary by [email protected] | Oct 18, 2023
Pharmacological interventions for drug-using offenders: An update to a systematic review and meta-analysis by [email protected] | Oct 18, 2023
Measuring fidelity to delivery of a new smoking cessation intervention integrated into routine tuberculosis care in Pakistan and Bangladesh: Contextual differences and opportunities by [email protected] | Oct 18, 2023
